{"url_path":"/sec/xlo/10-q/2026/item-3","section_key":"item-3","section_title":"Item 3 Quantitative and Qualitative Disclosures About Market Risk","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1840233/0001193125-26-218200-index.html","accession_number":"0001193125-26-218200","cik":"0001840233","ticker":"XLO","issuer_name":"Xilio Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1840233/0001193125-26-218200-index.html","primary_entity_key":"0001840233","primary_entity_name":"Xilio Therapeutics, Inc."},"word_count":35,"has_tables":true,"body_markdown":"# Item 3. Quantitative and Qualitative Disclosures About Market Risk\n\nWe are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item."}